日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results

Camonsertib(一种ATRi)联合低剂量吉西他滨治疗伴有DNA损伤反应异常的实体瘤:临床前和Ib期研究结果

Rosen, Ezra Y; Yap, Timothy A; Fontana, Elisa; Lee, Elizabeth K; Mahalingam, Devalingam; Højgaard, Martin; Mettu, Niharika B; Cote, Gregory M; Plummer, Ruth; Koehler, Maria; Ulanet, Danielle; Fei, Kezhen; Silverman, Ian M; Schonhoft, Joseph D; Rimkunas, Victoria; Bacque, Emeline S; Gomez, Gabriela; Fretland, Adrian J; Roulston, Anne; Li, Li; Baruah, Prasamit; Zimmermann, Michal; Yang, Julia; Carneiro, Benedito A; Lheureux, Stephanie

Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab

组织非特异性全基因组甲基化组富集检测方法的临床验证,用于监测帕博利珠单抗的疗效

Stutheit-Zhao, Eric Y; Zhong, Yongqi; Melton, Collin A; Lightbody, Elizabeth D; Hinterberg, Michael A; Wang, Yarong; Hall, Owen; Sosa, Eduardo V; Provance, Jeremy B; Zhang, Junjun; Licon, Abel; Liu, Zhihui Amy; Abdul Razak, Albiruni R; Spreafico, Anna; Bedard, Philippe L; Hansen, Aaron R; Lheureux, Stephanie; Ohashi, Pamela S; Williams, Alan; Bratman, Scott V; Allen, Brian A; Zhang, Jing; De Carvalho, Daniel D; Hartman, Anne-Renee; Siu, Lillian L; Sanz-Garcia, Enrique

Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report.

针对罕见侵袭性混合型子宫内膜癌的 VEGF 和 PI3K 联合治疗的临床前研究:应用病例报告。

Radulovich Nikolina, Pina Pamela Soberanis, Udaskin Molly L, Li Quan, Nixon Kevin C J, Xie Irene Y, Nand Ankita, Rosen Joshua C, Li Ming, Hodgson Anjelica, Pham Nhu-An, Oza Amit M, Lupien Mathieu, Rottapel Robert, Tsao Ming-Sound, Lheureux Stephanie

Impact of Body Mass Index on the Outcomes of Intensive Complex Decongestive Therapy for Lower Limb Lymphedema

体重指数对下肢淋巴水肿强化综合消肿疗法疗效的影响

Warnier, Marie; Antoniolli, Nina; Bihin, Benoit; Frippiat, Jacqueline; Meseeuw, Chloé; Lheureux, Alexis; Deltombe, Thierry

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

一线乐伐替尼联合帕博利珠单抗对比化疗治疗晚期子宫内膜癌:一项随机、开放标签的III期试验

Marth, Christian; Moore, Richard G; Bidziński, Mariusz; Pignata, Sandro; Ayhan, Ali; Rubio, M Jesús; Beiner, Mario; Hall, Marcia; Vulsteke, Christof; Braicu, Elena Ioana; Sonoda, Kenzo; Wu, Xiaohua; Frentzas, Sophia; Mattar, André; Lheureux, Stephanie; Chen, Xiaojun; Hasegawa, Kosei; Magallanes-Maciel, Manuel; Choi, Chel Hun; Shalkova, Mariia; Kaen, Diego; Wang, Peng-Hui; Berger, Regina; Okpara, Chinyere E; McKenzie, Jodi; Yao, Lili; Orlowski, Robert; Khemka, Vivek; Gilbert, Lucy; Makker, Vicky

Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer

癌症成年患者生命末期新型全身抗癌治疗及医疗服务利用情况

Iqbal, Javaid; Moineddin, Rahim; Quinn, Kieran L; Booth, Christopher M; Earle, Craig C; Lheureux, Stephanie; Grant, Robert; Lau, Jenny; Le, Lisa W; Tanuseputro, Peter; Downar, James; Rodin, Gary; Seow, Hsien; Tsai, Jillian; Fowler, Robert A; Hannon, Breffni; Krzyzanowska, Monika K; Zimmermann, Camilla

Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion.

p53 缺失后诱导慢性病毒模拟可促进免疫逃逸。

Ishak Charles A, Marhon Sajid A, Tchrakian Naïri, Hodgson Anjelica, Loo Yau Helen, Gonzaga Isabela M, Peralta Melanie, Lungu Ilinca M, Gomez Stephanie, Liang Sheng-Ben, Shen Shu Yi, Chen Raymond, Chen Jocelyn, Chatterjee Biji, Wanniarachchi Kevin N, Lee Junwoo, Zehrbach Nicholas, Hosseini Amir, Mehdipour Parinaz, Sun Siyu, Solovyov Alexander, Ettayebi Ilias, Francis Kyle E, He Aobo, Wu Taiyi, Feng Shengrui, da Silva Medina Tiago, Campos de Almeida Felipe, Bayani Jane, Li Jason, MacDonald Spencer, Wang Yadong, Garcia Sarah S, Arthofer Elisa, Diab Noor, Srivastava Aneil, Austin Paul Tran, Sabatini Peter J B, Greenbaum Benjamin D, O'Brien Catherine A, Shepherd Trevor G, Tsao Ming Sound, Chiappinelli Katherine B, Oza Amit M, Clarke Blaise A, Rottapel Robert, Lheureux Stephanie, De Carvalho Daniel D

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer

复发性子宫内膜癌对卡博替尼和纳武利尤单抗治疗的反应和耐药性的免疫学生物标志物

Roudko, Vladimir; Del Valle, Diane Marie; Radkevich, Emir; Kelly, Geoffrey; Hui, Xie; Patel, Manishkumar; Gonzalez-Kozlova, Edgar; Tuballes, Kevin; Streicher, Howard; Atale, Swati; Wang, Lisa; CzinCzin, Benito; Kim-Schulze, Seunghee; Wistuba, Ignacio I; Haymaker, Cara L; Al-Atrash, Gheath; Manyam, Ganiraju; Zhang, Jianjun; Thompson, Ryan; Suarez-Farinas, Mayte; Lheureux, Stephanie; Gnjatic, Sacha

Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial)

贝伐珠单抗联合每周一次阿奈妥单抗或每周一次紫杉醇治疗铂类耐药/难治性高级别卵巢癌的随机 II 期研究(NCI 试验)

Alqaisi, Husam A; Cohn, David E; Chern, Jing-Yi; Duska, Linda R; Jewell, Andrea; Corr, Bradley R; Winer, Ira Seth; Girda, Eugenia; Crispens, Marta A; Dhani, Neesha C; Madariaga, Ainhoa; Grant, Robert C; Malaguti, Matthew; Lee, Crystal; Bowering, Valerie; Wong, Horace; Poothullil, Andrew; Speers, Vanessa; Wang, Lisa; Bedard, Philippe L; Brady, John C; Nixon, Andrew B; Chen, Li; O'Connor, Claire; Zamboni, William; McKee, Tawyna; Moscow, Jeffrey A; Oza, Amit M; Lheureux, Stephanie

Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors

对接受过大量预处理的DNA损伤反应缺陷型肿瘤患者的液体活检样本进行基因组和表观基因组ctDNA分析

Silverman, Ian M; Schonhoft, Joseph D; Herzberg, Benjamin; Yablonovitch, Arielle; Lagow, Errin; Fiaux, Patrick C; Safabakhsh, Pegah; Sethuraman, Sunantha; Ulanet, Danielle; Yang, Julia; Kim, Insil; Basciano, Paul; Cecchini, Michael; Lee, Elizabeth; Lheureux, Stephanie; Fontana, Elisa; Carneiro, Benedito A; Reis-Filho, Jorge S; Yap, Timothy A; Zinda, Michael; Rosen, Ezra Y; Rimkunas, Victoria